Hyperoside protects against chronic mild stress-induced learning and memory deficits. 2017

Yeli Gong, and Youhua Yang, and Xiaoqing Chen, and Min Yang, and Dan Huang, and Rong Yang, and Lianying Zhou, and Changlei Li, and Qiuju Xiong, and Zhe Xiong
Department of Immunology, Medical College, Jianghan University, Wuhan 430056, China.

Hyperoside (quercetin-3-O-b-d-galactosidepyranose) is a plant-derived flavonoid mainly found in fruits, fruit juices (most notably flavanols, flavanones, and anthocyanins) and Chinese traditional medicines. It has been applied to relieve pain and improve cardiovascular functions in clinic. However, the effects of hyperoside on cognitive impairment induced by chronic stress and the underlying molecular mechanisms remain unclear. In the current study, we used chronic mild stress (CMS) rats to investigate the effects of hyperoside on learning and memory and further explore the possible mechanisms. Our results demonstrated that hyperoside reduced the escape latency and the swimming distance of CMS rats in Morris water maze test and reversed depressive symptoms in forced swim test (FST) and sucrose preference test. In addition, hyperoside increased the expression of brain-derived neurotrophic factor (BDNF) in hippocampus of CMS rats without influencing the corticosterone (CORT) level in blood plasma. Furthermore, K252a, an inhibitor of the BDNF receptor TrkB, prevented the protective effects of hyperoside on learning and memory in CMS rats. Taken together, these results indicate that hyperoside reverses the cognitive impairment induced by CMS, which is associated with the regulation of BDNF signaling pathway.

UI MeSH Term Description Entries
D007858 Learning Relatively permanent change in behavior that is the result of past experience or practice. The concept includes the acquisition of knowledge. Phenomenography
D008297 Male Males
D008569 Memory Disorders Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions. Memory Loss,Age-Related Memory Disorders,Memory Deficits,Memory Disorder, Semantic,Memory Disorder, Spatial,Memory Disorders, Age-Related,Retention Disorders, Cognitive,Semantic Memory Disorder,Spatial Memory Disorder,Age Related Memory Disorders,Age-Related Memory Disorder,Cognitive Retention Disorder,Cognitive Retention Disorders,Deficit, Memory,Deficits, Memory,Memory Deficit,Memory Disorder,Memory Disorder, Age-Related,Memory Disorders, Age Related,Memory Disorders, Semantic,Memory Disorders, Spatial,Memory Losses,Retention Disorder, Cognitive,Semantic Memory Disorders,Spatial Memory Disorders
D011794 Quercetin A flavonol widely distributed in plants. It is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin. 3,3',4',5,7-Pentahydroxyflavone,Dikvertin
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D006624 Hippocampus A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation. Ammon Horn,Cornu Ammonis,Hippocampal Formation,Subiculum,Ammon's Horn,Hippocampus Proper,Ammons Horn,Formation, Hippocampal,Formations, Hippocampal,Hippocampal Formations,Hippocampus Propers,Horn, Ammon,Horn, Ammon's,Proper, Hippocampus,Propers, Hippocampus,Subiculums

Related Publications

Yeli Gong, and Youhua Yang, and Xiaoqing Chen, and Min Yang, and Dan Huang, and Rong Yang, and Lianying Zhou, and Changlei Li, and Qiuju Xiong, and Zhe Xiong
November 2017, Nutritional neuroscience,
Yeli Gong, and Youhua Yang, and Xiaoqing Chen, and Min Yang, and Dan Huang, and Rong Yang, and Lianying Zhou, and Changlei Li, and Qiuju Xiong, and Zhe Xiong
January 2009, Clinics (Sao Paulo, Brazil),
Yeli Gong, and Youhua Yang, and Xiaoqing Chen, and Min Yang, and Dan Huang, and Rong Yang, and Lianying Zhou, and Changlei Li, and Qiuju Xiong, and Zhe Xiong
February 2008, Behavioural brain research,
Yeli Gong, and Youhua Yang, and Xiaoqing Chen, and Min Yang, and Dan Huang, and Rong Yang, and Lianying Zhou, and Changlei Li, and Qiuju Xiong, and Zhe Xiong
January 2005, Hippocampus,
Yeli Gong, and Youhua Yang, and Xiaoqing Chen, and Min Yang, and Dan Huang, and Rong Yang, and Lianying Zhou, and Changlei Li, and Qiuju Xiong, and Zhe Xiong
June 2016, Psychopharmacology,
Yeli Gong, and Youhua Yang, and Xiaoqing Chen, and Min Yang, and Dan Huang, and Rong Yang, and Lianying Zhou, and Changlei Li, and Qiuju Xiong, and Zhe Xiong
November 2020, Molecular biology reports,
Yeli Gong, and Youhua Yang, and Xiaoqing Chen, and Min Yang, and Dan Huang, and Rong Yang, and Lianying Zhou, and Changlei Li, and Qiuju Xiong, and Zhe Xiong
July 2019, Pakistan journal of pharmaceutical sciences,
Yeli Gong, and Youhua Yang, and Xiaoqing Chen, and Min Yang, and Dan Huang, and Rong Yang, and Lianying Zhou, and Changlei Li, and Qiuju Xiong, and Zhe Xiong
January 2008, Brain research,
Yeli Gong, and Youhua Yang, and Xiaoqing Chen, and Min Yang, and Dan Huang, and Rong Yang, and Lianying Zhou, and Changlei Li, and Qiuju Xiong, and Zhe Xiong
January 2022, Frontiers in oncology,
Yeli Gong, and Youhua Yang, and Xiaoqing Chen, and Min Yang, and Dan Huang, and Rong Yang, and Lianying Zhou, and Changlei Li, and Qiuju Xiong, and Zhe Xiong
December 2011, Acta pharmacologica Sinica,
Copied contents to your clipboard!